Amneal Pharmaceuticals, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of AMRX for the last quarter is 701.78 M USD, and it's 6.46% higher compared to the previous quarter. The net income of Q2 24 is 5.99 M USD.